• Targeted Gene Mutation Panel, Solid Organ Neoplasm (PancreaSeq)
  • Hepatitis C Virus (HCV) NS3/4A Protease Inhibitor Resistance, GenoSure
  • Polycystic kidney disease
  • Vitamin B1 (Thiamin)
  • HelioLiverâ„¢ Methylation Assay for Hepatocellular Carcinoma
  • Beta-2 Adrenergic Receptor (ADRB2) Gene Variation
  • Paroxetine, Serum
  • Midazolam, Urine
  • Vaginosis/Vaginitis Pathogen Detection Panel by Molecular Method
  • Biopsy, Blood Vessel
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS
Medical Test

Methodology
Access to Sarcoma Gene Mutation, Fusion and Rearrangement Panel, NGS is restricted.